Skip to content
Biodatica
Start free

JOINT CLINICAL RESEARCH CENTER

Kampala

Oncologygene therapyGrant-only
Compare Sign in to watch

What changed

NIH R01 · $0.7M · In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles

5w agoGrant renewalJun 9, 2026Source filing (opens the source filing in a new tab)

Momentum

56no change

Momentum 56 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    D43 · $269k · non-dilutive

    Jul 1, 2025

    JOINT CLINICAL RESEARCH CENTER · PI KITYO, CISSY · FIC · award ends Mar 31, 2030 · Leveraging North-South Partnerships toAdvance Cell and Gene Therapy for HIV Research Training Capacity in Uganda (C and GT-Uganda)

    NIH RePORTER · NIH RePORTER 11175215 (opens the source filing in a new tab)

  2. Grant

    R35 · $384k · non-dilutive

    Aug 15, 2023

    UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI TAYLOR, JUSTIN · NIGMS · award ends Jul 31, 2028 · The role of XPO1 in nuclear export of RNA

    NIH RePORTER · NIH RePORTER 11137125 (opens the source filing in a new tab)

  3. Grant

    R01 · $619k · non-dilutive

    Jul 5, 2022

    UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ADAIR, JENNIFER EILEEN · NIAID · award ends Jun 30, 2027 · Targeted genetic engineering of B cells to induce protective antibody responses to pathogens

    NIH RePORTER · NIH RePORTER 11315200 (opens the source filing in a new tab)

  4. Grant

    R01 · $717k · non-dilutive

    Jun 8, 2022

    UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ADAIR, JENNIFER EILEEN · NIAID · award ends May 31, 2027 · In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles

    NIH RePORTER · NIH RePORTER 11319709 (opens the source filing in a new tab)

  5. Grant

    P01 · $608k · non-dilutive

    Apr 4, 2019

    UNIVERSITY OF WASHINGTON · PI TAYLOR, JUSTIN J · NCI · award ends Jul 31, 2030 · MCPyV immunity: T cells, B cells & clinical significance

    NIH RePORTER · NIH RePORTER 11094607 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources